Dr. Jennifer Renee Tavernetti, MD

Dr. Tavernetti practices at Pacific Skin Institute in Sacramento, California.

Dr. Tavernetti's NPI, 1538549373, was assigned on June 7, 2015. Dr. Tavernetti graduated from Renaissance School of Medicine at Stony Brook University in 2015. Dr. Tavernetti holds California license A144905.

Dr. Tavernetti's primary practice is Pacific Skin Institute, at 1495 River Park Dr, Sacramento, CA 95815 in Sacramento County. The practice phone is (916) 925-7020.

Dr. Tavernetti's primary practice is Pacific Skin Institute in Sacramento, California. The medical group on file is Pacific Skin Institute. Dmand AI also links Dr. Tavernetti to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tavernetti practices. Vendor and product names are available with a free account.

Dermatology is Dr. Tavernetti's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Tavernetti is board certified in dermatology by the American Board of Dermatology. Dr. Tavernetti is licensed in California.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, itchy rashes, psoriasis, rash, scalp rash and shingles among the conditions Dr. Tavernetti treats.

CMS data shows 533 Medicare services from Dr. Tavernetti across 8 procedure codes in 2024, for 149 Medicare patients. Medicare paid $22,052 for them. Every service was in an office.

CMS counts 149 Medicare patients who saw Dr. Tavernetti in 2024. The largest group is 65 to 74, with 87 patients. 57% of them have high blood pressure, and 54% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tavernetti's median patient age at 43, with 59% women.

In 2024, Dr. Tavernetti wrote 418 Medicare Part D claims for 120 patients. 77% of them were for generic drugs. CMS names the drug for 307 of them, across 13 drugs with 11 or more claims each, at $224,971 in total drug cost. In 2023, CMS named 309 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Tavernetti for performance year 2024, reported as part of a group. Dr. Tavernetti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 404 procedures of removal of skin lesions by Dr. Tavernetti, more than 84% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Tavernetti. Dr. Tavernetti's most frequent co-authors are Maija Helena Tuulia Kiuru, MD, PhD, Ashfaq A. Marghoob, MD and Zaeem Nazir, MD.

CMS Open Payments shows 51 general payments to Dr. Tavernetti from 20 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 94% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $376.

Dr. Tavernetti graduated from Renaissance School of Medicine at Stony Brook University in 2015.

Dr. Tavernetti is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.